Relevium Welcomes Award-Winning Marketing Executive to Its Advisory Board
June 23 2020 - 8:15AM
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to
announce the appointment of Mr. James Mansour, an award-winning
brand and marketing executive to its advisory board.
Mr. James Mansour is an award-winning branding
authority who works closely with Global Brands to ensure success.
Mr. Mansour was instrumental in the development of many brands that
became icons in the marketplace and multi-billion-dollar businesses
including Victoria’s Secret, the #1 Lingerie Brand in the world,
and Bath and Body Works, the #1 Beauty Products Specialty Retailer
in the world.
James is an award-winning brand marketer and
customer experience authority, master at crafting compelling,
powerful and resonant consumer brand experiences. An authentic,
influential and successful industry leader with over 25 years of
experience; as both an executive and international consultant.
Mansour's unique background provides a broad
spectrum of significant business acumen in branding &
marketing, including concept development, product design, and
promotion. This blend of disciplines delivers a rare combination of
style and substance; seasoned strategic thinking, inspired ideas
and hands-on experience.
Well-versed in the needs of global corporations
like 3M and Corian and highly experienced in navigating the demands
of emerging companies, Mansour Design specializes in integrating
brands across all media - delivering clarity, consistency and
engaging interactivity which elevates brands and drives target
customers to new products online and on-shelf.
Aurelio Useche stated: “On behalf of our board
and team, we are proud to welcome James to our advisory board. His
global perspective and world class experience will support the next
phase in development of our company, and help us create customer
experiences that have sustainable resonance with consumers that
will result in long-term growth for our company”.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
About Relevium Technologies
Relevium is a publicly traded Company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition, and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe.
Relevium’s premium brands are sold at some of
the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical Company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes
certain statements and information that may constitute
forward-looking information within the meaning of applicable
Canadian and United States securities laws. All statements in this
news release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives,
assumptions, or expectations of future performance, are
forward-looking statements and contain forward-looking information.
Generally, forward- looking statements and information can be
identified by the use of forward-looking terminology such as
"intends" or "anticipates", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "should", or "would" occur. Forward-looking
statements are based on certain material assumptions and analysis
made by the Company and the opinions and estimates of management as
of the date of this press release. These forward-looking statements
are subject to known and unknown risks, uncertainties and other
factors that may cause the actual results, level of activity,
performance or achievements of the Company to be materially
different from those expressed or implied by such forward-looking
statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press
release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES
INCEmail: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on FacebookFollow us on
Twitter Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024